HPV Testing & Pap Test Market By Test Type (HPV test, Pap Test, Co-test), By Application (Cervical Cancer, Vaginal Cancer), By Location of Testing (Hospitals and clinics, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global HPV testing & Pap test market was valued at $ 3655.97 million in 2021, and is projected to reach $ 6647.36 million by 2031, registering a CAGR of 6.1% from 2022 to 2031.
Human Papillomavirus (HPV) is a group of approximately 150 related viruses. These viruses are able to survive in squamous epithelial cells, thus infect cervical and vaginal cells which cause abnormalities in cervical cells leading to cervical or vaginal cancer. In addition, to avoid advanced stage cervical cancer, screening through HPV testing, Pap test or combination of both is recommended. HPV testing is used to detect human Papillomavirus in the cervix, which can lead to cervical cancer. The Pap test is a smear test that provides an accurate screening measure to determine whether cervical cells are abnormal or normal. Individuals who have abnormal cells in their Pap test are advised to have the human Papillomavirus test for further evaluation of cervical cancer.
The driving factors for HPV testing and Pap test market are the increasing number of cervical cancer cases across the globe, and rise in number of cervical cancer screening programs, and the educating people regarding early screening. For instance, according to the report of World Health Organization (WHO) in 2020, stated that more than half a million women contracted cervical cancer, and about 342,000 women died as a result. In addition, WHO’s global strategy for cervical cancer elimination, endorsed by the World Health Assembly in 2020, stated that 70% of women globally to be screened regularly for cervical disease with a high-performance test like HPV test, Pap smear test or combine test i.e., co-test. Further, the growing number of cervical cancer cases increases the demand for screening programs. The persisting burden of cervical cancer in underserved populations and low-resource regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive strategies and expanded screening options to maintain and improve screening coverage further, drives the growth of HPV testing and Pap test market.
However, changes in regulatory guidelines for cervical cancer screening restrains the growth of HPV testing and Pap test market. In addition, availability of human Papillomavirus vaccination across the globe also might hinder the growth of market.
The global HPV testing & Pap test market is segmented into test type, application, location of testing and region. By test type, the market is categorized into HPV test, Pap test and co-test. On the basis of application, the market is segregated into cervical cancer and vaginal cancer. On the basis of location of testing, the market is categorized into hospitals and clinics, diagnostic centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global HPV testing & Pap test market are Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company (BD), F. Hoffmann-La Roche AG, Femasys, Hologic Inc., Mylab Discovery Solutions Pvt. Ltd, Qaigen NV, Seegene Inc and Thermo Fischer Scientific Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hpv testing & pap test market analysis from 2021 to 2031 to identify the prevailing hpv testing & pap test market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the hpv testing & pap test market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global hpv testing & pap test market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Test Type
HPV test
Pap Test
Co-test
By Application
Cervical Cancer
Vaginal Cancer
By Location of Testing
Hospitals and clinics
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Arbor vita corporation
Becton, Dickinson and Company
Femasys Inc.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Mylab Discovery Solutions Pvt. Ltd
Seegene Inc
Hologic Inc.
F. Hoffmann-La Roche AG
Qaigen NV
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.1.1. Government initiatives and funding for cervical cancer
- 3.4.1.2. Increase in prevalence of cervical cancer cases
- 3.4.1.3. Increase in awareness regarding cervical cancer
- 3.4.2.Restraints
- 3.4.2.1. Human papillomavirus vaccination
- 3.4.2.2. Changes in regulatory guidelines and uncertain reimbursement schemes for cervical cancer
- 3.4.3.Opportunities
- 3.4.3.1. Growth opportunities in emerging markets
- 3.5.COVID-19 Impact Analysis on the market
- CHAPTER 4: HPV TESTING & PAP TEST MARKET, BY TEST TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2. HPV test
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3. Pap Test
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4. Co-test
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- CHAPTER 5: HPV TESTING & PAP TEST MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2. Cervical Cancer
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3. Vaginal Cancer
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- CHAPTER 6: HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2. Hospitals and clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3. Diagnostic Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4. Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
- CHAPTER 7: HPV TESTING & PAP TEST MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Test Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by Location of Testing
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Key market trends, growth factors and opportunities
- 7.2.5.1.2 Market size and forecast, by Test Type
- 7.2.5.1.3 Market size and forecast, by Application
- 7.2.5.1.4 Market size and forecast, by Location of Testing
- 7.2.5.2 Canada
- 7.2.5.2.1 Key market trends, growth factors and opportunities
- 7.2.5.2.2 Market size and forecast, by Test Type
- 7.2.5.2.3 Market size and forecast, by Application
- 7.2.5.2.4 Market size and forecast, by Location of Testing
- 7.2.5.3 Mexico
- 7.2.5.3.1 Key market trends, growth factors and opportunities
- 7.2.5.3.2 Market size and forecast, by Test Type
- 7.2.5.3.3 Market size and forecast, by Application
- 7.2.5.3.4 Market size and forecast, by Location of Testing
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Test Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by Location of Testing
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Key market trends, growth factors and opportunities
- 7.3.5.1.2 Market size and forecast, by Test Type
- 7.3.5.1.3 Market size and forecast, by Application
- 7.3.5.1.4 Market size and forecast, by Location of Testing
- 7.3.5.2 France
- 7.3.5.2.1 Key market trends, growth factors and opportunities
- 7.3.5.2.2 Market size and forecast, by Test Type
- 7.3.5.2.3 Market size and forecast, by Application
- 7.3.5.2.4 Market size and forecast, by Location of Testing
- 7.3.5.3 UK
- 7.3.5.3.1 Key market trends, growth factors and opportunities
- 7.3.5.3.2 Market size and forecast, by Test Type
- 7.3.5.3.3 Market size and forecast, by Application
- 7.3.5.3.4 Market size and forecast, by Location of Testing
- 7.3.5.4 Italy
- 7.3.5.4.1 Key market trends, growth factors and opportunities
- 7.3.5.4.2 Market size and forecast, by Test Type
- 7.3.5.4.3 Market size and forecast, by Application
- 7.3.5.4.4 Market size and forecast, by Location of Testing
- 7.3.5.5 Spain
- 7.3.5.5.1 Key market trends, growth factors and opportunities
- 7.3.5.5.2 Market size and forecast, by Test Type
- 7.3.5.5.3 Market size and forecast, by Application
- 7.3.5.5.4 Market size and forecast, by Location of Testing
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Key market trends, growth factors and opportunities
- 7.3.5.6.2 Market size and forecast, by Test Type
- 7.3.5.6.3 Market size and forecast, by Application
- 7.3.5.6.4 Market size and forecast, by Location of Testing
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Test Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by Location of Testing
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Key market trends, growth factors and opportunities
- 7.4.5.1.2 Market size and forecast, by Test Type
- 7.4.5.1.3 Market size and forecast, by Application
- 7.4.5.1.4 Market size and forecast, by Location of Testing
- 7.4.5.2 China
- 7.4.5.2.1 Key market trends, growth factors and opportunities
- 7.4.5.2.2 Market size and forecast, by Test Type
- 7.4.5.2.3 Market size and forecast, by Application
- 7.4.5.2.4 Market size and forecast, by Location of Testing
- 7.4.5.3 India
- 7.4.5.3.1 Key market trends, growth factors and opportunities
- 7.4.5.3.2 Market size and forecast, by Test Type
- 7.4.5.3.3 Market size and forecast, by Application
- 7.4.5.3.4 Market size and forecast, by Location of Testing
- 7.4.5.4 Australia
- 7.4.5.4.1 Key market trends, growth factors and opportunities
- 7.4.5.4.2 Market size and forecast, by Test Type
- 7.4.5.4.3 Market size and forecast, by Application
- 7.4.5.4.4 Market size and forecast, by Location of Testing
- 7.4.5.5 South Korea
- 7.4.5.5.1 Key market trends, growth factors and opportunities
- 7.4.5.5.2 Market size and forecast, by Test Type
- 7.4.5.5.3 Market size and forecast, by Application
- 7.4.5.5.4 Market size and forecast, by Location of Testing
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Key market trends, growth factors and opportunities
- 7.4.5.6.2 Market size and forecast, by Test Type
- 7.4.5.6.3 Market size and forecast, by Application
- 7.4.5.6.4 Market size and forecast, by Location of Testing
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Test Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by Location of Testing
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Key market trends, growth factors and opportunities
- 7.5.5.1.2 Market size and forecast, by Test Type
- 7.5.5.1.3 Market size and forecast, by Application
- 7.5.5.1.4 Market size and forecast, by Location of Testing
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Key market trends, growth factors and opportunities
- 7.5.5.2.2 Market size and forecast, by Test Type
- 7.5.5.2.3 Market size and forecast, by Application
- 7.5.5.2.4 Market size and forecast, by Location of Testing
- 7.5.5.3 South Africa
- 7.5.5.3.1 Key market trends, growth factors and opportunities
- 7.5.5.3.2 Market size and forecast, by Test Type
- 7.5.5.3.3 Market size and forecast, by Application
- 7.5.5.3.4 Market size and forecast, by Location of Testing
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Key market trends, growth factors and opportunities
- 7.5.5.4.2 Market size and forecast, by Test Type
- 7.5.5.4.3 Market size and forecast, by Application
- 7.5.5.4.4 Market size and forecast, by Location of Testing
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
- CHAPTER 9: COMPANY PROFILES
- 9.1 Arbor vita corporation
- 9.1.1 Company overview
- 9.1.2 Key Executives
- 9.1.3 Company snapshot
- 9.1.4 Operating business segments
- 9.1.5 Product portfolio
- 9.1.6 Business performance
- 9.1.7 Key strategic moves and developments
- 9.2 Becton, Dickinson and Company
- 9.2.1 Company overview
- 9.2.2 Key Executives
- 9.2.3 Company snapshot
- 9.2.4 Operating business segments
- 9.2.5 Product portfolio
- 9.2.6 Business performance
- 9.2.7 Key strategic moves and developments
- 9.3 Femasys Inc.
- 9.3.1 Company overview
- 9.3.2 Key Executives
- 9.3.3 Company snapshot
- 9.3.4 Operating business segments
- 9.3.5 Product portfolio
- 9.3.6 Business performance
- 9.3.7 Key strategic moves and developments
- 9.4 Abbott Laboratories
- 9.4.1 Company overview
- 9.4.2 Key Executives
- 9.4.3 Company snapshot
- 9.4.4 Operating business segments
- 9.4.5 Product portfolio
- 9.4.6 Business performance
- 9.4.7 Key strategic moves and developments
- 9.5 Thermo Fisher Scientific Inc.
- 9.5.1 Company overview
- 9.5.2 Key Executives
- 9.5.3 Company snapshot
- 9.5.4 Operating business segments
- 9.5.5 Product portfolio
- 9.5.6 Business performance
- 9.5.7 Key strategic moves and developments
- 9.6 Mylab Discovery Solutions Pvt. Ltd
- 9.6.1 Company overview
- 9.6.2 Key Executives
- 9.6.3 Company snapshot
- 9.6.4 Operating business segments
- 9.6.5 Product portfolio
- 9.6.6 Business performance
- 9.6.7 Key strategic moves and developments
- 9.7 Seegene Inc
- 9.7.1 Company overview
- 9.7.2 Key Executives
- 9.7.3 Company snapshot
- 9.7.4 Operating business segments
- 9.7.5 Product portfolio
- 9.7.6 Business performance
- 9.7.7 Key strategic moves and developments
- 9.8 Hologic Inc.
- 9.8.1 Company overview
- 9.8.2 Key Executives
- 9.8.3 Company snapshot
- 9.8.4 Operating business segments
- 9.8.5 Product portfolio
- 9.8.6 Business performance
- 9.8.7 Key strategic moves and developments
- 9.9 F. Hoffmann-La Roche AG
- 9.9.1 Company overview
- 9.9.2 Key Executives
- 9.9.3 Company snapshot
- 9.9.4 Operating business segments
- 9.9.5 Product portfolio
- 9.9.6 Business performance
- 9.9.7 Key strategic moves and developments
- 9.10 Qaigen NV
- 9.10.1 Company overview
- 9.10.2 Key Executives
- 9.10.3 Company snapshot
- 9.10.4 Operating business segments
- 9.10.5 Product portfolio
- 9.10.6 Business performance
- 9.10.7 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 2. HPV TESTING & PAP TEST MARKET FOR HPV TEST, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 3. HPV TESTING & PAP TEST MARKET FOR PAP TEST, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 4. HPV TESTING & PAP TEST MARKET FOR CO-TEST, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 5. GLOBAL HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 6. HPV TESTING & PAP TEST MARKET FOR CERVICAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 7. HPV TESTING & PAP TEST MARKET FOR VAGINAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 8. GLOBAL HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 9. HPV TESTING & PAP TEST MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. HPV TESTING & PAP TEST MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. HPV TESTING & PAP TEST MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. HPV TESTING & PAP TEST MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. U.S. HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. U.S. HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. U.S. HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. CANADA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. CANADA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. CANADA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. MEXICO HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. MEXICO HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. MEXICO HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. EUROPE HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. EUROPE HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. EUROPE HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. EUROPE HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. GERMANY HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. GERMANY HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. GERMANY HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. FRANCE HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. FRANCE HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. FRANCE HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. UK HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. UK HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. UK HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. ITALY HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. ITALY HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. ITALY HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. SPAIN HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. SPAIN HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. SPAIN HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. REST OF EUROPE HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. REST OF EUROPE HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. REST OF EUROPE HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. JAPAN HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. JAPAN HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. JAPAN HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. CHINA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. CHINA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. CHINA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. INDIA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. INDIA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. INDIA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. AUSTRALIA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. AUSTRALIA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. AUSTRALIA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. SOUTH KOREA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. SOUTH KOREA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. SOUTH KOREA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 70. LAMEA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 71. LAMEA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 72. LAMEA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 73. LAMEA HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 74. BRAZIL HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 75. BRAZIL HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 76. BRAZIL HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 77. SAUDI ARABIA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 78. SAUDI ARABIA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 79. SAUDI ARABIA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 80. SOUTH AFRICA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 81. SOUTH AFRICA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 82. SOUTH AFRICA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 83. REST OF LAMEA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 84. REST OF LAMEA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 85. REST OF LAMEA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
- TABLE 86. ARBOR VITA CORPORATION: KEY EXECUTIVES
- TABLE 87. ARBOR VITA CORPORATION: COMPANY SNAPSHOT
- TABLE 88. ARBOR VITA CORPORATION: OPERATING SEGMENTS
- TABLE 89. ARBOR VITA CORPORATION: PRODUCT PORTFOLIO
- TABLE 90. ARBOR VITA CORPORATION: NET SALES
- TABLE 91. ARBOR VITA CORPORATION: KEY STRATERGIES
- TABLE 92. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 93. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 94. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 95. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 96. BECTON, DICKINSON AND COMPANY: NET SALES
- TABLE 97. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
- TABLE 98. FEMASYS INC.: KEY EXECUTIVES
- TABLE 99. FEMASYS INC.: COMPANY SNAPSHOT
- TABLE 100. FEMASYS INC.: OPERATING SEGMENTS
- TABLE 101. FEMASYS INC.: PRODUCT PORTFOLIO
- TABLE 102. FEMASYS INC.: NET SALES
- TABLE 103. FEMASYS INC.: KEY STRATERGIES
- TABLE 104. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 105. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 106. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 107. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 108. ABBOTT LABORATORIES: NET SALES
- TABLE 109. ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 110. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
- TABLE 111. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- TABLE 112. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
- TABLE 113. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
- TABLE 114. THERMO FISHER SCIENTIFIC INC.: NET SALES
- TABLE 115. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
- TABLE 116. MYLAB DISCOVERY SOLUTIONS PVT. LTD: KEY EXECUTIVES
- TABLE 117. MYLAB DISCOVERY SOLUTIONS PVT. LTD: COMPANY SNAPSHOT
- TABLE 118. MYLAB DISCOVERY SOLUTIONS PVT. LTD: OPERATING SEGMENTS
- TABLE 119. MYLAB DISCOVERY SOLUTIONS PVT. LTD: PRODUCT PORTFOLIO
- TABLE 120. MYLAB DISCOVERY SOLUTIONS PVT. LTD: NET SALES
- TABLE 121. MYLAB DISCOVERY SOLUTIONS PVT. LTD: KEY STRATERGIES
- TABLE 122. SEEGENE INC: KEY EXECUTIVES
- TABLE 123. SEEGENE INC: COMPANY SNAPSHOT
- TABLE 124. SEEGENE INC: OPERATING SEGMENTS
- TABLE 125. SEEGENE INC: PRODUCT PORTFOLIO
- TABLE 126. SEEGENE INC: NET SALES
- TABLE 127. SEEGENE INC: KEY STRATERGIES
- TABLE 128. HOLOGIC INC.: KEY EXECUTIVES
- TABLE 129. HOLOGIC INC.: COMPANY SNAPSHOT
- TABLE 130. HOLOGIC INC.: OPERATING SEGMENTS
- TABLE 131. HOLOGIC INC.: PRODUCT PORTFOLIO
- TABLE 132. HOLOGIC INC.: NET SALES
- TABLE 133. HOLOGIC INC.: KEY STRATERGIES
- TABLE 134. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
- TABLE 135. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
- TABLE 136. F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
- TABLE 137. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
- TABLE 138. F. HOFFMANN-LA ROCHE AG: NET SALES
- TABLE 139. F. HOFFMANN-LA ROCHE AG: KEY STRATERGIES
- TABLE 140. QAIGEN NV: KEY EXECUTIVES
- TABLE 141. QAIGEN NV: COMPANY SNAPSHOT
- TABLE 142. QAIGEN NV: OPERATING SEGMENTS
- TABLE 143. QAIGEN NV: PRODUCT PORTFOLIO
- TABLE 144. QAIGEN NV: NET SALES
- TABLE 145. QAIGEN NV: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1. SEGMENTATION OF HPV TESTING & PAP TEST MARKET,2021-2031
- FIGURE 2. HPV TESTING & PAP TEST MARKET,2021-2031
- FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 4. PORTER FIVE-1
- FIGURE 5. PORTER FIVE-2
- FIGURE 6. PORTER FIVE-3
- FIGURE 7. PORTER FIVE-4
- FIGURE 8. PORTER FIVE-5
- FIGURE 9. HPV TESTING & PAP TEST MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 10. HPV TESTING & PAP TEST MARKET,BY TEST TYPE,2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF HPV TEST HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PAP TEST HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CO-TEST HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 14. HPV TESTING & PAP TEST MARKET,BY APPLICATION,2021(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CERVICAL CANCER HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VAGINAL CANCER HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 17. HPV TESTING & PAP TEST MARKET,BY LOCATION OF TESTING,2021(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTERS HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF OTHERS HPV TESTING & PAP TEST MARKET, 2021 AND 2031(%)
- FIGURE 21. HPV TESTING & PAP TEST MARKET BY REGION,2021
- FIGURE 22. U.S. HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 23. CANADA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 24. MEXICO HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 25. GERMANY HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 26. FRANCE HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 27. UK HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 28. ITALY HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 29. SPAIN HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 30. REST OF EUROPE HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 31. JAPAN HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 32. CHINA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 33. INDIA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 34. AUSTRALIA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 35. SOUTH KOREA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 36. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 37. BRAZIL HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 38. SAUDI ARABIA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 39. SOUTH AFRICA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 40. REST OF LAMEA HPV TESTING & PAP TEST MARKET,2021-2031($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45. COMPETITIVE DASHBOARD
- FIGURE 46. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 47. TOP PLAYER POSITIONING, 2021
- FIGURE 48. ARBOR VITA CORPORATION.: NET SALES ($MILLION)
- FIGURE 49. BECTON, DICKINSON AND COMPANY.: NET SALES ($MILLION)
- FIGURE 50. FEMASYS INC..: NET SALES ($MILLION)
- FIGURE 51. ABBOTT LABORATORIES.: NET SALES ($MILLION)
- FIGURE 52. THERMO FISHER SCIENTIFIC INC..: NET SALES ($MILLION)
- FIGURE 53. MYLAB DISCOVERY SOLUTIONS PVT. LTD.: NET SALES ($MILLION)
- FIGURE 54. SEEGENE INC.: NET SALES ($MILLION)
- FIGURE 55. HOLOGIC INC..: NET SALES ($MILLION)
- FIGURE 56. F. HOFFMANN-LA ROCHE AG.: NET SALES ($MILLION)
- FIGURE 57. QAIGEN NV.: NET SALES ($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook